Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK ,The Lancet Respiratory Medic

Analysis of data from CCP-UK (n=75,463) found those with severe asthma or COPD had increased mortality rates, after adjustment for a range of comorbidities. Use of inhaled steroids ≤2 weeks of admission was associated with decreased mortality in those with asthma aged ≥50 years
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news